Kikuchi-Fujimoto disease following SARS CoV2 vaccination: Case report
<p dir="ltr">Kikuchi's disease (KD) also known as Kikuchi-Fujimoto disease (KFD), or histiocytic necrotizing lymphadenitis was first described in 1972 independently by Kikuchi and Fujimoto et al. It is a benign self-limited condition of unknown etiology which usually presents wi...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , |
| منشور في: |
2021
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513547810111488 |
|---|---|
| author | Hussam Al Soub (17269024) |
| author2 | Wanis Ibrahim (14777290) Muna Al Maslamani (12204862) Gawahir A. Ali (14182300) Waseem Ummer (17269108) Ala’ Abu-Dayeh (17269111) |
| author2_role | author author author author author |
| author_facet | Hussam Al Soub (17269024) Wanis Ibrahim (14777290) Muna Al Maslamani (12204862) Gawahir A. Ali (14182300) Waseem Ummer (17269108) Ala’ Abu-Dayeh (17269111) |
| author_role | author |
| dc.creator.none.fl_str_mv | Hussam Al Soub (17269024) Wanis Ibrahim (14777290) Muna Al Maslamani (12204862) Gawahir A. Ali (14182300) Waseem Ummer (17269108) Ala’ Abu-Dayeh (17269111) |
| dc.date.none.fl_str_mv | 2021-08-10T00:00:00Z |
| dc.identifier.none.fl_str_mv | 10.1016/j.idcr.2021.e01253 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/Kikuchi-Fujimoto_disease_following_SARS_CoV2_vaccination_Case_report/24420457 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Cardiovascular medicine and haematology Clinical sciences SARS CoV 2 Kikuchi Fujimoto Lymphadenopathy COVID 19 vaccine |
| dc.title.none.fl_str_mv | Kikuchi-Fujimoto disease following SARS CoV2 vaccination: Case report |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <p dir="ltr">Kikuchi's disease (KD) also known as Kikuchi-Fujimoto disease (KFD), or histiocytic necrotizing lymphadenitis was first described in 1972 independently by Kikuchi and Fujimoto et al. It is a benign self-limited condition of unknown etiology which usually presents with cervical lymphadenopathy or fever of unknown origin. The diagnosis of KFD is based on histopathologic examination of the involved lymph node, showing the presence of well-defined necrosis without granulocytic cells. There is no special treatment for KFD. However non-steroidal anti-inflammatory drugs or corticosteroids are required occasionally to control the associated systemic manifestations. The outcome of the disease is usually favorable with resolution of symptoms in most cases within one to four months. We report a case of Kikuchi-Fujimoto disease that occurred in a young Qatari male patient 10 days following receiving the first dose of BNT162b2 vaccine. Diagnosis was established by lymph node biopsy and recovery was complete after 10 days.</p><h2>Other Information</h2><p dir="ltr">Published in: IDCases<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.idcr.2021.e01253" target="_blank">https://dx.doi.org/10.1016/j.idcr.2021.e01253</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_2d6324b7de10c692033619c81aef3a6a |
| identifier_str_mv | 10.1016/j.idcr.2021.e01253 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/24420457 |
| publishDate | 2021 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Kikuchi-Fujimoto disease following SARS CoV2 vaccination: Case reportHussam Al Soub (17269024)Wanis Ibrahim (14777290)Muna Al Maslamani (12204862)Gawahir A. Ali (14182300)Waseem Ummer (17269108)Ala’ Abu-Dayeh (17269111)Biomedical and clinical sciencesCardiovascular medicine and haematologyClinical sciencesSARS CoV 2KikuchiFujimotoLymphadenopathyCOVID 19 vaccine<p dir="ltr">Kikuchi's disease (KD) also known as Kikuchi-Fujimoto disease (KFD), or histiocytic necrotizing lymphadenitis was first described in 1972 independently by Kikuchi and Fujimoto et al. It is a benign self-limited condition of unknown etiology which usually presents with cervical lymphadenopathy or fever of unknown origin. The diagnosis of KFD is based on histopathologic examination of the involved lymph node, showing the presence of well-defined necrosis without granulocytic cells. There is no special treatment for KFD. However non-steroidal anti-inflammatory drugs or corticosteroids are required occasionally to control the associated systemic manifestations. The outcome of the disease is usually favorable with resolution of symptoms in most cases within one to four months. We report a case of Kikuchi-Fujimoto disease that occurred in a young Qatari male patient 10 days following receiving the first dose of BNT162b2 vaccine. Diagnosis was established by lymph node biopsy and recovery was complete after 10 days.</p><h2>Other Information</h2><p dir="ltr">Published in: IDCases<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.idcr.2021.e01253" target="_blank">https://dx.doi.org/10.1016/j.idcr.2021.e01253</a></p>2021-08-10T00:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1016/j.idcr.2021.e01253https://figshare.com/articles/journal_contribution/Kikuchi-Fujimoto_disease_following_SARS_CoV2_vaccination_Case_report/24420457CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/244204572021-08-10T00:00:00Z |
| spellingShingle | Kikuchi-Fujimoto disease following SARS CoV2 vaccination: Case report Hussam Al Soub (17269024) Biomedical and clinical sciences Cardiovascular medicine and haematology Clinical sciences SARS CoV 2 Kikuchi Fujimoto Lymphadenopathy COVID 19 vaccine |
| status_str | publishedVersion |
| title | Kikuchi-Fujimoto disease following SARS CoV2 vaccination: Case report |
| title_full | Kikuchi-Fujimoto disease following SARS CoV2 vaccination: Case report |
| title_fullStr | Kikuchi-Fujimoto disease following SARS CoV2 vaccination: Case report |
| title_full_unstemmed | Kikuchi-Fujimoto disease following SARS CoV2 vaccination: Case report |
| title_short | Kikuchi-Fujimoto disease following SARS CoV2 vaccination: Case report |
| title_sort | Kikuchi-Fujimoto disease following SARS CoV2 vaccination: Case report |
| topic | Biomedical and clinical sciences Cardiovascular medicine and haematology Clinical sciences SARS CoV 2 Kikuchi Fujimoto Lymphadenopathy COVID 19 vaccine |